INGALLS & SNYDER LLC 13D and 13G filings for Concert Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-09 4:41 pm Sale | 2005-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | INGALLS & SNYDER LLC | 1,396,003 4.550% | -68,709 (-4.69%) | Filing |
2020-01-23 2:21 pm Purchase | 2005-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | INGALLS & SNYDER LLC | 1,464,712 6.100% | 264,937 (+22.08%) | Filing |